BREAKING: Senate Committee Advances Act to Prohibit U.S. Partnerships with Chinese Biopharma Companies
The Biosecure Act prohibits US biopharma from partnering with Chinese companies for the research and manufacturing of diagnostic and biosynthetic products, i.e. PCR tests and mRNA injections.
March 6, 2024: Today, the US Senate Homeland Security & Government Affairs Committee advanced (R) Mike Gallagher’s BIOSECURE Act with an overwhelming 11-to-1 vote. The Act would prohibit the US government from funding Chinese biotech companies that pose a threat to national security and prohibit U.S. pharma companies from working with certain Chinese m…
Keep reading with a 7-day free trial
Subscribe to The Kingston Report to keep reading this post and get 7 days of free access to the full post archives.